Goldman Sachs Group »

Urogen Pharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 114k 15.00
2023-09-30 $752k 54k 14.01
2023-06-30 $325k 31k 10.35
2023-03-31 $652k 71k 9.24
2022-12-31 $208k 24k 8.87
2022-06-30 $313k 38k 8.19
2022-03-31 $433k 50k 8.72
2021-12-31 $514k 54k 9.52
2021-09-30 $962k 57k 16.81
2021-03-31 $2.0M 103k 19.48
2020-12-31 $3.2M 175k 18.02
2020-09-30 $3.1M 160k 19.29
2020-06-30 $3.7M 143k 26.12
2019-12-31 $3.1M 94k 33.37
2019-09-30 $3.0M 127k 23.83
2019-06-30 $2.1M 58k 35.94
2019-03-31 $2.2M 59k 36.94
2018-12-31 $697k 16k 43.08
2018-09-30 $578k 12k 47.25
2018-06-30 $755k 15k 49.76
2018-03-31 $2.2M 45k 49.67
2017-12-31 $234k 6.3k 37.14